1. Razumilava N,
Gores G.J.
Cholangiocarinoma.
Lancet 2014 Jun 21;383(9935): 2168-79.
2. Yang,
J.D.,
Kim,
B.,
Sanderson,
S.O.,
Sauver,
J.S.,
Yawn,
B.P.,
Larson,
J.J.
et al, Biliary tract cancers in Olmsted County,
Minnesota,
1976–2008. Am J Gastroenterol. 2012;107:1256–1262.
3. Razumilava,
N.,
Gores,
G.J.
Classification,
diagnosis,
and management of cholangiocarcinoma.
ClinGastroenterolHepatol.
2013;11:13–21
4. Yamasaki S.
Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10:288–91.
5. Ringe K.I.,
Wacker F.
Radiological diagnosis in cholangiocarcinoma: Application of computed tomography,
magnetic resonance imaging,
and positron emission tomography.
Gastroenterology 2015;29(2):253-65.
6. Papafragkakis C,
Lee J.H.
Comprehensive management of cholangiocarcinoma: Part I.
Diagnosis.
Gastrointestinal Intervention 2017; 6(2): 85-93
7. Hennedige T.P,
Neo W.T,
Venkatesh S.K.
Imaging of malignancies of the biliary tract- an update.
Cancer Imaging.
2014; 14(1): 14.
8. Ros PR,
Buck JL,
Goodman ZD,
Ros AM,
Olmsted WW.
Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation.
Radiology.
1988;167:689–93.
9. Vilana R,
Forner A,
Bianchi L,
Garcia-Criado A,
Rimola J,
de Lope CR,
Reig M,
Ayuso C,
Brú C,
Bruix J.
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 2010;51:2020–9.
10. Bruix J,
Sherman M.
Management of hepatocellular carcinoma.
Hepatology.
2005;42:1208–36.
11. Sainani NI,
Catalano OA,
Holalkere NS,
Zhu AX,
Hahn PF,
Sahani DV.
Cholangiocarcinoma: current and novel imaging techniques.
Radiographics.
2008;28:1263–87.
12. Slattery JM,
Sahani DV.
What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist.
2006;11:913–22.
13. Kim TK,
Choi BI,
Han JK,
Jang HJ,
Cho SG,
Han MC.
Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings.
Radiology.
1997;204:539–43.
14. Lacomis JM,
Baron RL,
Oliver JH 3rd,
Nalesnik MA,
Ferderle MP.
Cholangiocarcinoma: delayed CT contrast enhancement patterns.
Radiology.
1997;203:98–104.
15. Loyer EM,
Chin H,
DuBrow RA,
David CL,
Eftekhari F,
Charnsangavej C.
Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: Enhancement patterns with quadruple phase helical CT—a comparative study.
Radiology.
1999;212:866–75.
16. Low RN.
MR imaging of the liver using gadolinium chelates.
MagnReson Imaging Clin N Am.
2001;9:717–43.
17. Chung YE,
Kim MJ,
Park YN,
Choi JY,
Pyo JY,
Kim YC,
Cho HJ,
Kim KA,
Choi SY.
Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation.
Radiographics.
2009;29:683–700.
18. Heinrich S,
Clavien PA.
Ampullary cancer.
CurrOpinGastroenterol.
2010;26(3):280–5.
19. Sharma MP,
Ahuja V.
Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician’s perspective.
Trop Gastroenterol.
1999;20:167–9.
20. Seo H,
Lee JM,
Kim IH,
Han JK,
Kim SH,
Jang JY,
Kim SW,
Choi BI.
Evaluation of the gross type and longitudinal extent of extrahepatic cholangiocarcinomas on contrast-enhanced multidetector row computed tomography. J Comput Assist Tomogr. 2009;33:376–82.
21. Lee HY,
Kim SH,
Lee JM,
Kim SW,
Jang JY,
Han JK,
Choi BI.
Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.
Radiology.
2006;239:113–21.
22. Vilgrain V.
Staging cholangiocarcinoma by imaging studies.
HPB (Oxford) 2008;10(2):106–9.
23. Choi JY,
Kim MJ,
Lee JM,
Kim KW,
Lee JY,
Han JK,
Choi BI.
Hilar cholangiocarcinoma: role of preoperative imaging with sonography,
MDCT,
MRI,
and direct cholangiography.
AJR Am J Roentgenol.
2008;191:1448–57.
24. Hänninen EL,
Pech M,
Jonas S,
Ricke J,
Thelen A,
Langrehr J,
Hintze R,
Röttgen R,
Denecke T,
Winter L,
Neuhaus P,
Felix R.
Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions.
ActaRadiol.
2005;46:462–70.
25. Masselli G,
Manfredi R,
Vecchioli A,
Gualdi G.
MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings.
EurRadiol.
2008;18:2213–21.
26. Lee MG,
Park KB,
Shin YM,
Yoon HK,
Sung KB,
Kim MH.
Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography.
World J Surg.
2003;27:278–83.
27. Marsh Rde W,
Alonzo M,
Bajaj S,
Baker M,
Elton E,
Farrell TA,
Gore RM,
Hall C,
Nowak J,
Roy H,
Shaikh A,
Talamonti MS.
Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012.
Part I: diagnosis-clinical staging and pathology. J SurgOncol. 2012;106:332–8.
28. Bridgewater J et al.
Gudelines for the diagnosis and management of intrahepatic cholangiocarcinoma.
J Hepatol (2014).
29. Chung Y.E.
et al.
Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic Correlation.
Radiographics.
2009;29(3).